• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

Comprehensive Overview of N4-(2-Methoxyethyl)pyridine-3,4-diamine (CAS No. 1039985-93-7)

N4-(2-Methoxyethyl)pyridine-3,4-diamine (CAS No. 1039985-93-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research due to its unique structural properties. This compound, often referred to as a pyridine derivative, features a methoxyethyl substituent at the N4 position, which enhances its solubility and reactivity. Researchers are particularly interested in its potential applications as a building block for drug discovery, especially in the development of kinase inhibitors and anticancer agents. Its molecular formula and precise structure make it a valuable candidate for medicinal chemistry studies.

In recent years, the demand for N4-(2-Methoxyethyl)pyridine-3,4-diamine has surged, driven by its role in high-throughput screening and combinatorial chemistry. The compound's ability to form stable intermediates makes it a preferred choice for synthesizing heterocyclic compounds, which are pivotal in modern drug design. Moreover, its low toxicity profile and biocompatibility have made it a subject of interest in bioconjugation and targeted therapy research. These attributes align with the growing trend of precision medicine, where researchers seek compounds with minimal side effects and high efficacy.

The synthesis of N4-(2-Methoxyethyl)pyridine-3,4-diamine involves multi-step organic reactions, including nucleophilic substitution and catalytic hydrogenation. Advanced techniques such as HPLC purification and NMR spectroscopy are employed to ensure its high purity, which is critical for pharmaceutical-grade applications. The compound's stability under various pH conditions further broadens its utility in formulation development, particularly for oral and injectable drugs. This versatility has positioned it as a key intermediate in the synthesis of bioactive molecules.

From an industrial perspective, N4-(2-Methoxyethyl)pyridine-3,4-diamine is increasingly used in contract research organizations (CROs) and API manufacturing. Its compatibility with green chemistry principles, such as reduced solvent usage and energy-efficient processes, aligns with the global push for sustainable chemical production. Additionally, its application in proteomics and genomics research has opened new avenues for studying cellular signaling pathways, making it a hot topic in biomedical conferences and scientific publications.

As the scientific community continues to explore the potential of N4-(2-Methoxyethyl)pyridine-3,4-diamine, its relevance in personalized medicine and drug repurposing cannot be overstated. The compound's structure-activity relationship (SAR) is a focal point for researchers aiming to optimize its pharmacological properties. With the rise of AI-driven drug discovery, computational models are being leveraged to predict its interactions with biological targets, further accelerating its adoption in preclinical studies. This intersection of chemistry and technology underscores its importance in the future of therapeutic innovation.

• 823202-94-4(1,4,7,10-Tetraoxa-13-azacyclopentadecane, 13-(3-pyridinyl)-)
• 847436-79-7(Ethanol, 2-[2-[(3-amino-4-quinolinyl)amino]ethoxy]-)
• 705-00-0(2-Propanol, 1-[(3-amino-4-pyridinyl)amino]-)
• 61719-62-8(N3-ethyl-3,4-Pyridinediamine)
• 1235440-71-7(N4-[2-(morpholin-4-yl)ethyl]pyridine-3,4-diamine dihydrochloride)
• 146950-67-6(4-N-ethylpyridine-3,4-diamine)
• 78070-10-7(3-Pyridinamine,4-(4-morpholinyl)-, hydrochloride (1:2))
• 78091-28-8(2-[4-(3-aminopyridin-4-yl)piperazin-1-yl]ethanol)
• 124897-41-2(2-[(3-aminopyridin-4-yl)amino]ethan-1-ol)
• 90648-26-3(4-(morpholin-4-yl)pyridin-3-amine)